Ignite Creation Date:
2024-05-06 @ 12:29 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03778619
Status:
UNKNOWN
Last Update Posted:
2020-07-28
First Post:
2018-11-07
Brief Title:
MG4101 Plus Rituximab Including Lymphodepletion in Patient With rr NHL B-cell Origin
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-07
First Submit QC Date:
December 14 2018
Study First Post Date:
2018-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-26
Last Update Post Date:
2020-07-28
Last Update Post Date Type:
ACTUAL